Levine Media Group
47 episodes listed below
PRESS PLAY
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Based on 4 episodes we listened to · September 2026
It makes pharmaceutical AI legible by tracing each ambition back to data foundations, compliance constraints and practical workflows.
Life Sciences DNA Podcast keeps returning to a practical question: what does it take to move AI from a promising demonstration into everyday pharmaceutical work? Its interviews examine that process through data infrastructure, organizational governance and commercial operations.
Even a lunch sign-in sheet is fair game when you ask what pharma AI could actually fix.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A grounded look at audit trails, adoption hurdles, and bench-work tradeoffs in robotic drug formulation.
Automating biopharma workflows looks at a practical shift: drug formulation work moving from the scientist's bench into a cloud-based robotic lab.
A grounded look at agentic AI in regulatory workflows without handing off judgment.
Regulatory document work is the useful proving ground here. Anita Modi, co-founder and CEO of Pure AI, describes agentic systems built from specialized agents and human oversight to draft clinical study reports, INDs, protocols, and submission documents.
A practical look at real-world data's value, limits, and continued need for medical judgment.
Real-world data enters this drug-development discussion as a practical counterweight to the tidy structure of randomized clinical trials. Manford, speaking from both medical and pharmaceutical experience, makes the case for retrospective data that can avoid patient recruitment…
A grounded look at making AI adoption work inside clinical development.
AI in clinical development comes through here as an operational change effort with technical weight behind it. In a conversation with Steven Pike, Chief Data and Digital Officer at Patexel, the host stays close to the work of adoption: identifying super users who understand both…
A clear, grounded review of adaptive cancer testing and its path from precision oncology research toward clinical use.
This single-episode review frames cancer diagnostics as something that has to keep up with the disease, not just name it once. Mohan Uttar, co-founder and CEO of OneCell.ai, is presented making the case for AI and single-cell analytics as a way to build a more current tumor…
A measured look at how AI becomes usable only after compliance, experts, and workflow all line up.
This episode stays close to the practical side of AI at Eversana, where the real question is not whether a model sounds impressive but whether it can survive a regulated life sciences environment.
A practical look at AI in commercial pharma, focused on making routine workflows less manual.
Manesh Naidoo and Daniel Levine keep the focus on a straightforward question: how AI can help a small pharmaceutical commercial team work better.
A practical look at why life sciences AI starts with data plumbing, not model spectacle.
This episode spends more time on the plumbing than the pitch, and that feels right. Shweta Maniar, presented as a global strategy and market leader for life sciences at Google Cloud, walks through data fragmentation, legacy systems, and the work needed to build something usable…
Mushroom culture from soil to society.
Clear neuroscience for curious minds.
Plant papers, jokes, and useful uncertainty.
Weed science, from genomes to paddocks.
Biomedical careers, described from the inside.
Human stakes behind biomedical progress.
Chief Commercial Officer Manesh Naidoo of Tris Pharma discusses practical AI implementation strategies for small pharmaceutical companies, covering sales force optimization, contract compliance, CRM enhancements, and risk mitigation approaches in commercial operations.
Scott Sensi, Chief Information and Data Officer at Arcadia Pharmaceuticals, discusses implementing AI across the drug development continuum, from medical writing transformation to change management strategies and future agentic AI applications in biopharma.
Google Cloud's Shweta Maniar discusses how AI is transforming life sciences, from reducing regulatory task time by 70% to helping scientists move from data reconciliation to high-value strategy.
["Scotch McCoy says Maxwell Biosciences started in January 2016 to use AI to narrow human plasma from about 100,000 proteins to the 3% of peptides that circulate outside cells.", "The company centered on LL37, the number-three longevity-correlated peptide, and McCoy says it licensed patents from Annalise Barron and other inventors after a settlement over ownership.", "He says a 160,000-peptide antimicrobial set was normalized to about 11,000 records, a model reached 90% toxicity-prediction accuracy, and Indian ICMR primate studies cleared MRSA and multidrug-resistant Candida albicans in three days.", "The episode also covers SHU, a \"structured heuristic understanding rag database,\" the idea of AI as the company\u2019s coordinating hub, and plans to extend the platform to antivirals, antifungals, GLP-1-like targets, and BDNF mimics."]
Drew McCormick, head of data and analytics at Eversana, shares a practical blueprint for scaling AI across commercial life sciences teams.
Kartik Raman, CEO and co-founder of Persist AI, describes replacing manual pharmaceutical formulation workflows with cloud laboratories, robotics, and AI-assisted experimentation.
Life Sciences DNA hosts Sri and Danny interview Anita Modi, CEO and founder of Peer AI, about using agentic AI to create clinical and regulatory documents.
The Life Sciences DNA Podcast examines how Manfred Staff applies real-world data and AI to drug development, regulation, and healthcare decisions.
Life Sciences DNA Podcast interviews Steven Pike, Patexel's Chief Data and Digital Officer, about adopting AI across clinical development.
Life Sciences DNA Podcast interviews Mohan Uttar, co-founder and CEO of OneCell.ai, about using AI, liquid biopsy, and single-cell analytics in cancer diagnostics and therapy development.
Life Sciences DNA Podcast examines how Amar Drawood separates rules-based automation, predictive machine learning, and generative AI across biopharma.